Park In-Su, Chung Phil-Sang, Ahn Jin Chul, Leproux Anais
Beckman Laser Institute Korea, Dankook University, 119 Dandae-ro, Cheonan, Chungnam, 330-714, South Korea.
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Dankook University, 119 Dandae-ro, Cheonan, Chungnam, 330-714, South Korea.
Lasers Med Sci. 2017 Nov;32(8):1737-1746. doi: 10.1007/s10103-017-2239-1. Epub 2017 Jun 27.
Skin flap grafting is a form of transplantation widely used in plastic surgery. However, ischemia/reperfusion injury is the main factor which reduces the survival rate of flaps following grafting. We investigated whether photobiomodulation (PBM) precondition prior to human adipose-derived stromal cell (hASC) spheroid (PBM-spheroid) transplantation improved skin tissue functional recovery by the stimulation of angiogenesis and tissue regeneration in skin flap of mice. The LED had an emission wavelength peaked at 660 ± 20 nm (6 J/cm, 10 mW/cm). The expression of angiogenic growth factors in PBM-spheroid hASCs was much greater than that of not-PBM-treated spheroid or monolayer-cultured hASCs. From immunochemical staining analysis, the hASCs of PBM-spheroid were CD31, KDR, and CD34, whereas monolayer-cultured hASCs were negative for these markers. To evaluate the therapeutic effect of hASC PBM-spheroid in vivo, PBS, monolayer-cultured hASCs, and not-PBM-spheroid were transplanted into a skin flap model. The animals were observed for 14 days. The PBM-spheroid hASCs transplanted into the skin flap ischemia differentiated into endothelial cells and remained differentiated. Transplantation of PBM-spheroid hASCs into the skin flap ischemia significantly elevated the density of vascular formations through angiogenic factors released by the skin flap ischemia and enhanced tissue regeneration at the lesion site. Consistent with these results, the transplantation of PBM-spheroid hASCs significantly improved functional recovery compared with PBS, monolayer-cultured hASCs, and not-PBM-spheroid treatment. These findings suggest that transplantation of PBM-spheroid hASCs may be an effective stem cell therapy for the treatment of skin flap ischemia.
皮瓣移植是整形手术中广泛应用的一种移植形式。然而,缺血/再灌注损伤是降低移植后皮瓣存活率的主要因素。我们研究了在人脂肪来源的基质细胞(hASC)球体(PBM球体)移植前进行光生物调节(PBM)预处理是否能通过刺激小鼠皮瓣中的血管生成和组织再生来改善皮肤组织功能恢复。发光二极管的发射波长峰值为660±20nm(6J/cm²,10mW/cm²)。PBM球体hASC中血管生成生长因子的表达远高于未进行PBM处理的球体或单层培养的hASC。免疫化学染色分析显示,PBM球体的hASC表达CD31、KDR和CD34,而单层培养的hASC对这些标志物呈阴性。为了评估hASC PBM球体在体内的治疗效果,将磷酸盐缓冲盐水(PBS)、单层培养的hASC和未进行PBM处理的球体移植到皮瓣模型中。对动物观察14天。移植到皮瓣缺血区域的PBM球体hASC分化为内皮细胞并保持分化状态。将PBM球体hASC移植到皮瓣缺血区域可通过皮瓣缺血释放的血管生成因子显著提高血管形成密度,并增强损伤部位的组织再生。与这些结果一致,与PBS、单层培养的hASC和未进行PBM处理的球体治疗相比,PBM球体hASC的移植显著改善了功能恢复。这些发现表明,PBM球体hASC的移植可能是治疗皮瓣缺血的一种有效干细胞疗法。